 Oscar Health fell as much as 9 in its IPO trading debut on Wednesday, giving it a valuation of about 9 billion. Oscar had priced its IPO at 39 per share, selling 37 million shares 1 higher than its previously targeted offering range of 36-38. Oscar had originally planned to sell 31 million shares at a price between 32-34 in its initial IPO filings. The firm raised 1.4 billion in proceeds from the offering. 